指南与共识生殖医学

不孕症核心结局指标集的定义标准化与报告指南:国际共识制定研究

Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study† ‡.
指南 / 共识 · Hum Reprod · 2020-01-01

本研究通过系统综述和面对面共识会议,为不孕症核心结局指标集制定共识定义、背景说明和标准化报告表格。该标准化方法旨在减少选择性报告,改善研究结果报告和临床指南制定。

要点

  • 为不孕症所有核心结局制定共识定义。
  • 开发标准化报告表格以规范报告。
  • 减少选择性报告,提升研究质量。

核心结论

  • 成功为不孕症所有核心结局制定共识定义。
  • 制定了背景说明和标准化报告表格。
  • 共识定义和报告建议可减少选择性报告,改善研究二次分析和临床指南制定。

研究设计与样本

  • 通过系统综述定义发展倡议和临床实践指南以及Cochrane妇科与生育组指南识别潜在定义。
  • 召开面对面共识发展会议,采用正式共识制定方法。

主要发现

  • 成功为所有核心结局制定共识定义。
  • 提出具体建议以改进报告。

临床怎么用

  • 最低数据集应帮助研究人员填写方案、病例报告表和其他数据收集工具。
  • 通用报告表格应为研究人员提供明确指导,改善期刊发表和会议报告中的结果报告。
  • 研究资助机构、SPIRIT声明和80多种专业期刊已承诺实施该核心结局指标集。

局限性

  • 共识制定方法具有固有局限性。
  • 来自低收入和中等收入国家的代表有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can consensus definitions for the core outcome set for infertility be identified in order to recommend a standardized approach to reporting? SUMMARY ANSWER: Consensus definitions for individual core outcomes, contextual statements and a standardized reporting table have been developed. WHAT IS KNOWN ALREADY: Different definitions exist for individual core outcomes for infertility. This variation increases the opportunities for researchers to engage with selective outcome reporting, which undermines secondary research and compromises clinical practice guideline development. STUDY DESIGN, SIZE, DURATION: Potential definitions were identified by a systematic review of definition development initiatives and clinical practice guidelines and by reviewing Cochrane Gynaecology and Fertility Group guidelines. These definitions were discussed in a face-to-face consensus development meeting, which agreed consensus definitions. A standardized approach to reporting was also developed as part of the process. PARTICIPANTS/MATERIALS, SETTING, METHODS: Healthcare professionals, researchers and people with fertility problems were brought together in an open and transparent process using formal consensus development methods. MAIN RESULTS AND THE ROLE OF CHANCE: Forty-four potential definitions were inventoried across four definition development initiatives, including the Harbin Consensus Conference Workshop Group and International Committee for Monitoring Assisted Reproductive Technologies, 12 clinical practice guidelines and Cochrane Gynaecology and Fertility Group guidelines. Twenty-seven participants, from 11 countries, contributed to the consensus development meeting. Consensus definitions were successfully developed for all core outcomes. Specific recommendations were made to improve reporting. LIMITATIONS, REASONS FOR CAUTION: We used consensus development methods, which have inherent limitations. There was limited representation from low- and middle-income countries. WIDER IMPLICATIONS OF THE FINDINGS: A minimum data set should assist researchers in populating protocols, case report forms and other data collection tools. The generic reporting table should provide clear guidance to researchers and improve the reporting of their results within journal publications and conference presentations. Research funding bodies, the Standard Protocol Items: Recommendations for Interventional Trials statement, and over 80 specialty journals have committed to implementing this core outcome set. STUDY FUNDING/COMPETING INTEREST(S): This research was funded by the Catalyst Fund, Royal Society of New Zealand, Auckland Medical Research Fund and Maurice and Phyllis Paykel Trust. Siladitya Bhattacharya reports being the Editor-in-Chief of Human Reproduction Open and an editor of the Cochrane Gynaecology and Fertility Group. J.L.H.E. reports being the Editor Emeritus of Human Reproduction. R.S.L. reports consultancy fees from Abbvie, Bayer, Ferring, Fractyl, Insud Pharma and Kindex and research sponsorship from Guerbet and Hass Avocado Board. B.W.M. reports consultancy fees from Guerbet, iGenomix, Merck, Merck KGaA and ObsEva. C.N. reports being the Editor-in-Chief of Fertility and Sterility and Section Editor of the Journal of Urology, research sponsorship from Ferring, and a financial interest in NexHand. E.H.Y.N. reports research sponsorship from Merck. A.S. reports consultancy fees from Guerbet. J.W. reports being a statistical editor for the Cochrane Gynaecology and Fertility Group. A.V. reports that he is a Statistical Editor of the Cochrane Gynaecology & Fertility Review Group and of the journal Reproduction. His employing institution has received payment from Human Fertilisation and Embryology Authority for his advice on review of research evidence to inform their 'traffic light' system for infertility treatment 'add-ons'. N.L.V. reports consultancy and conference fees from Ferring, Merck and Merck Sharp and Dohme. The remaining authors declare no competing interests in relation to the work presented. All authors have completed the disclosure form. TRIAL REGISTRATION NUMBER: Core Outcome Measures in Effectiveness Trials Initiative: 1023.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Duffy JMN, Bhattacharya S, Bhattacharya S, et al. Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study† ‡. Hum Reprod. 2020. PMID: 33252643. doi:10.1093/humrep/deaa243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。